Ann: Appendix 3B, page-10

The eagle eyed amongst you might have notice in my previous post I indicated my sentiment...
I usually stick with the default 'None' but the sp had slid well into oversold territory just simply on a news lull.

In 2018 there should be much fewer lengthy lulls, especially if the new local assay prep facility comes on line. T3 is already stunning and with so many other targets so I think it's appropriate to reaffirm my sentiment... 'Buy'!